- Previous Close
717.95 - Open
707.20 - Bid 695.30 x --
- Ask 697.95 x --
- Day's Range
690.00 - 707.20 - 52 Week Range
672.75 - 977.95 - Volume
2,182 - Avg. Volume
3,709 - Market Cap (intraday)
76.594B - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
109.21 - EPS (TTM)
6.38 - Earnings Date Feb 12, 2025 - Feb 13, 2025
- Forward Dividend & Yield 1.25 (0.17%)
- Ex-Dividend Date Sep 18, 2024
- 1y Target Est
710.44
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
www.anupamrasayan.com1,896
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: ANURAS.BO
View MorePerformance Overview: ANURAS.BO
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ANURAS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ANURAS.BO
View MoreValuation Measures
Market Cap
78.93B
Enterprise Value
91.28B
Trailing P/E
112.36
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.48
Price/Book (mrq)
2.84
Enterprise Value/Revenue
7.53
Enterprise Value/EBITDA
28.72
Financial Highlights
Profitability and Income Statement
Profit Margin
6.99%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
13.43B
Net Income Avi to Common (ttm)
939.16M
Diluted EPS (ttm)
6.38
Balance Sheet and Cash Flow
Total Cash (mrq)
3.54B
Total Debt/Equity (mrq)
36.51%
Levered Free Cash Flow (ttm)
--